OBJECTIVE: The purpose of this study was to document some of the results of a comprehensive provincial cytology and colposcopy program for the year 1988 and also to review the impact on the incidence and mortality rates for a clinical carcinoma of the cervix. STUDY DESIGN: This study is a retrospective analysis of the cytologic results of all patients examined provincially in 1988 and a review of the clinical records of patients diagnosed with invasive cancer and those who died of disease. RESULTS: In 1988 490,985 women (40% of all women over the age of 15 in the population) were screened, with 9.2% showing abnormal cells. A total of 79% of women screened were less than 50 years old and accounted for 86.3% of all abnormal smears. Women less than 35 years old were more likely than older women to have moderate dyskaryosis or worse. CONCLUSION: Intensive comprehensive cytology and colposcopy programs reduce not only the incidence and mortality of clinical carcinoma of the cervix but also rates of in situ disease and other precursors.
OBJECTIVE: The purpose of this study was to document some of the results of a comprehensive provincial cytology and colposcopy program for the year 1988 and also to review the impact on the incidence and mortality rates for a clinical carcinoma of the cervix. STUDY DESIGN: This study is a retrospective analysis of the cytologic results of all patients examined provincially in 1988 and a review of the clinical records of patients diagnosed with invasive cancer and those who died of disease. RESULTS: In 1988 490,985 women (40% of all women over the age of 15 in the population) were screened, with 9.2% showing abnormal cells. A total of 79% of women screened were less than 50 years old and accounted for 86.3% of all abnormal smears. Women less than 35 years old were more likely than older women to have moderate dyskaryosis or worse. CONCLUSION: Intensive comprehensive cytology and colposcopy programs reduce not only the incidence and mortality of clinical carcinoma of the cervix but also rates of in situ disease and other precursors.
Authors: D Major; D Armstrong; H Bryant; W Cheung; K Decker; G Doyle; V Mai; C M McLachlin; J Niu; J Payne; N Shukla Journal: Curr Oncol Date: 2015-08 Impact factor: 3.677
Authors: Lisa M Korst; Kimberly D Gregory; Michael C Lu; Carolina Reyes; Calvin J Hobel; Gilberto F Chavez Journal: Matern Child Health J Date: 2005-09
Authors: David E Gerber; Heidi A Hamann; Noel O Santini; Suhny Abbara; Hsienchang Chiu; Molly McGuire; Lisa Quirk; Hong Zhu; Simon J Craddock Lee Journal: Contemp Clin Trials Date: 2017-07-05 Impact factor: 2.226